ArticleFrontiers in cellular and infection microbiology2026
Temporal trends and mortality associated with difficult-to-treat resistance in bloodstream gram-negative bacilli: a retrospective cohort study in Southern Saudi Arabia.
Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Antimicrobial resistance among bloodstream gram-negative bacilli is a major driver of infectious-disease mortality, yet broad resistance labels can obscure clinically important heterogeneity. We aimed to characterise long-term organism and resistance trends, including difficult-to-treat resistance (DTR), among bloodstream gram-negative bacilli and to estimate their association with 30-day in-hospital mortality. Methods: We conducted a retrospective cohort study of hospitalized patients aged 12 years or older with blood cultures yielding Enterobacterales or non-fermenting gram-negative bacilli (GNB) at a 500-bed tertiary hospital in Southern Saudi Arabia from 1 January 2013 to 27 August 2024. Duplicates within 14 days were excluded; trends were analyzed with segmented binomial regression and mortality with modified Poisson regression adjusted for age, sex, intensive-care status, infection source, healthcare-associated infection, COVID-19 era, calendar year and Elixhauser comorbidity score. Results: Among 2027 isolate-episodes from 1695 patients, 1487 (73.4%) were Enterobacterales and 540 (26.6%) non-fermenting GNB. The organism mix was broadly stable, but Discussion: In this surveillance cohort, escalating carbapenem resistance and DTR, rather than a shifting organism mix, were associated with worse outcomes, supporting surveillance based on treatment-option phenotypes and prioritization of stewardship and infection-prevention efforts against high-risk GNB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.